Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04089813
Other study ID # XYFY2019-0003
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date September 10, 2019
Est. completion date December 31, 2020

Study information

Verified date September 2019
Source Xuzhou Medical University
Contact Jin Dong Liu, M.S
Phone +86-13951355136
Email liujindong1818@163.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Metformin has been found to have more and more functions as a commonly used hypoglycemic drug in clinic. It has been found that metformin has anti-inflammatory, anti-tumor and lipid metabolism regulating effects. Basic studies have shown that metformin as an adjuvant drug combined with gabapentin and tramadol is safe and effective in patients with neuropathic pain. Postoperative chronic pain as a common complication has seriously affected the quality of life and mood of patients after surgery.Some studies have shown that chronic pain after partial operation manifests as neuropathic pain. The effect of metformin on chronic pain after thoracic surgery in patients with diabetes mellitus was observed in this experiment, which was compared with patients taking insulin to control blood sugar.


Description:

The analgesic mechanism of metformin may include the following aspects:(1)Metformin relieves neuropathic pain mainly because it can activate adenosine monophosphate-activated protein kinase (AMPK), which plays a crucial role in pain regulation as an important endogenous kinase controlling energy metabolism.(2)In addition, metformin can also inhibit ERK signaling pathway, further inhibit sodium channel, prevent the development of peripheral sensitization and achieve the effect of relieving neuropathic pain. (3)Metformin has been shown to alleviate bone cancer pain in rats by reducing STAT3 phosphorylation.Clinical research in this field is limited to basic research and ethical requirements are rarely reported at home and abroad. Li Chunye et al. of Jiangsu University designed a clinical trial to compare the efficacy of metformin and gabapentin combined with tramadol on neuropathic pain. The results showed that metformin had a better effect.

The incidence of chronic pain after thoracic surgery is higher. Postoperative chronic pain is a complex pain. The nature and mechanism of chronic pain after thoracic surgery are still controversial. Some studies have shown that some chronic pain after thoracic surgery manifests neuropathic pain, the mechanism may be related to surgical incision, nerve injury caused by trauma and increased pain sensitization. Can metformin alleviate chronic pain after surgery? The research on this aspect is still blank at present.This study was designed as a prospective cohort study to observe whether there was a difference in the incidence of chronic pain after thoracoscopic lobectomy between patients taking metformin and patients injecting insulin to control blood sugar.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 200
Est. completion date December 31, 2020
Est. primary completion date December 9, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria:

1. Aged between 18 and 70

2. Diabetes history. Use metformin or insulin to control blood sugar

3. The type of operation is selective thoracoscopic lobectomy.

Exclusion Criteria:

1. Newly diagnosed diabetic patients at admission

2. Complication of severe cardiopulmonary diseases

3. Refuse to participate in this experiment

4. Participate in other trials

5. Patients with diabetic complications (including diabetic nephropathy, peripheral neuropathy, etc.)

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Metformin
Patients use metformin to control blood sugar

Locations

Country Name City State
China The Affiliated Hospital of Xuzhou Medical University Xuzhou Jiangsu

Sponsors (1)

Lead Sponsor Collaborator
Xuzhou Medical University

Country where clinical trial is conducted

China, 

References & Publications (4)

Ge A, Wang S, Miao B, Yan M. Effects of metformin on the expression of AMPK and STAT3 in the spinal dorsal horn of rats with neuropathic pain. Mol Med Rep. 2018 Apr;17(4):5229-5237. doi: 10.3892/mmr.2018.8541. Epub 2018 Feb 1. — View Citation

Pecikoza UB, Tomic MA, Micov AM, Stepanovic-Petrovic RM. Metformin Synergizes With Conventional and Adjuvant Analgesic Drugs to Reduce Inflammatory Hyperalgesia in Rats. Anesth Analg. 2017 Apr;124(4):1317-1329. doi: 10.1213/ANE.0000000000001561. — View Citation

Shiers S, Pradhan G, Mwirigi J, Mejia G, Ahmad A, Kroener S, Price T. Neuropathic Pain Creates an Enduring Prefrontal Cortex Dysfunction Corrected by the Type II Diabetic Drug Metformin But Not by Gabapentin. J Neurosci. 2018 Aug 15;38(33):7337-7350. doi: — View Citation

Smith B, Ang D. Metformin: Potential analgesic? Pain Med. 2015 Dec;16(12):2256-60. doi: 10.1111/pme.12816. Epub 2015 May 29. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Incidence of chronic pain after operation A VAS score greater than or equal to 3 is defined as the presence of chronic pain after surgery. 3 months after operation
Secondary VAS score at extubation time, 12 hours and 24 hours after operation A VAS score greater than or equal to 3 is defined as the presence of pain after surgery. extubation time, 12 hours and 24 hours after operation
Secondary Neuropathic pain score and incidence at 3 months after operation Assessment of the presence of neuropathic pain by using self-rating scale 3 months after operation
Secondary Anxiety and Depression Score Assessment of Anxiety and Depression in Patients by HAMD Depression Scale 3 months after operation
Secondary Length of ICU stay Some patients may need to be transferred to ICU. an average of 2 days
Secondary Length of hospital stay Total length of hospitalization an average of 10 days
See also
  Status Clinical Trial Phase
Recruiting NCT05492669 - Intravenous Lidocaine on Chronic Pain in Patients Undergoing Hepatectomy Phase 2